111 (YI) Interest & Investment Income (2017 - 2025)
111's (YI) quarterly Interest & Investment Income came in at $415000.0 in Q3 2025, down 47.73% year-on-year from $794000.0 in Q3 2024, and up 30.91% quarter-over-quarter from $317000.0 in Q2 2025.
111 (YI) Interest & Investment Income (2017 - 2025) Analysis & Trends
111 has disclosed Interest & Investment Income across 9 years of filings, most recently posting $415000.0 for Q3 2025.
- Interest & Investment Income for Q3 2025 came in at $415000.0, down 47.73% year-over-year; the trailing twelve-month figure through Sep 2025 was $415000.0 (down 47.73% YoY), and the FY2025 annual result was $556000.0, down 42.38% from the prior year.
- Interest & Investment Income came in at $415000.0 for Q3 2025 at 111, up from $317000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.3 million in Q3 2021 to a low of $173000.0 in Q1 2025.
- The 5-year median for Interest & Investment Income is $517000.0 (2022), against an average of $578066.7.
- Across the five-year window, Interest & Investment Income soared 1058.54% in 2021 and tumbled 47.73% in 2025, its largest moves.
- 111's Interest & Investment Income stood at $1.3 million in 2021, then sank by 33.57% to $847000.0 in 2022, then increased by 5.43% to $893000.0 in 2023, then dropped by 11.09% to $794000.0 in 2024, then sank by 47.73% to $415000.0 in 2025.
- The last three Interest & Investment Income figures came in at $415000.0 (Q3 2025), $317000.0 (Q2 2025), and $173000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Akso Health | 2,315,158.81 Bn | 2,315,158.63 Bn | - | - |
| 2 | Mckesson | 92.76 Bn | 89.18 Bn | 4.04 Bn | - |
| 3 | Cencora | 52.82 Bn | 50.83 Bn | 3.59 Bn | -140.46 Mn |
| 4 | Cardinal Health | 52.17 Bn | 48.39 Bn | 2.50 Bn | - |
| 5 | Henry Schein | 9.19 Bn | 9.71 Bn | 1.07 Bn | 7.00 Mn |
| 6 | Accendra Health | 246.88 Mn | -90.00 Mn | 312.39 Mn | - |
| 7 | Edap Tms | 161.92 Mn | 146.92 Mn | 8.15 Mn | -1.71 Mn |
| 8 | 111 | 107.47 Mn | 25.61 Mn | 23.58 Mn | - |
| 9 | Cosmos Health | 9.42 Mn | 7.26 Mn | 1.38 Mn | 46,673.00 |
| 10 | Cellyan Biotechnology | 5.69 | -2.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 415,000.00 |
| Jun 30, 2025 | 317,000.00 |
| Mar 31, 2025 | 173,000.00 |
| Sep 30, 2024 | 794,000.00 |
| Jun 30, 2024 | 556,000.00 |
| Mar 31, 2024 | 272,000.00 |
| Sep 30, 2023 | 893,000.00 |
| Jun 30, 2023 | 573,000.00 |
| Mar 31, 2023 | 284,000.00 |
| Sep 30, 2022 | 847,000.00 |
| Jun 30, 2022 | 517,000.00 |
| Mar 31, 2022 | 322,000.00 |
| Sep 30, 2021 | 1.28 Mn |
| Jun 30, 2021 | 958,000.00 |
| Mar 31, 2021 | 475,000.00 |
| Sep 30, 2020 | 603,000.00 |
| Jun 30, 2020 | 199,000.00 |
| Mar 31, 2020 | 41,000.00 |
| Sep 30, 2019 | 626,000.00 |
| Jun 30, 2019 | 489,000.00 |